Last month, Lilly announced that orforglipron, an orally available GLP-1 treatment, significantly lowered blood glucose levels in patients with type 2 diabetes
Available as: Last cited 6 Sept 2023 Urva S, OFarrell L, Du Y, Loh MT, Hemmingway A, Qu H, Alsina-Fernandez J, Haupt A, Milicevic Z, Coskun T (2023) The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying
Plasma donation eligibility whilst taking Wegovy depends on NHS Blood and Transplant (NHSBT) guidelines, your overall health status, and how well you tolerate the medication
Praa C, Rosa SC, Sevin E, Cecchelli R, Dehouck MP, Ferreira LS
Just because it is not extremely common does not mean it wont happen to you
And patience beats dose increases almost every time